Aprea Therapeutics, Inc.
New Filing
CIK: 0001781983·Biotechnology·DELAWARE·Filed: Dec 23, 2025
Total Offering
$5,783,766
Amount Sold
$3,055,822
Investors
8
First Sale
Dec 10, 2025
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
Related Persons
| Name | Role |
|---|---|
| Oren Gilad | Executive Officer, Director |
| John P. Hamill | Executive Officer |
| Richard Peters | Director |
| Jean-Pierre Bizzari | Director |
| Marc Duey | Director |
| Michael Grissinger | Director |
| Gabriela Gruia | Director |
| John B. Henneman | Director |
| Rifat Pamukcu | Director |
| Bernd Seizinger | Director |
Company
SEC Filing
0001781983-25-000003
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free